S. Ravilly

1.6k total citations
38 papers, 1.2k citations indexed

About

S. Ravilly is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, S. Ravilly has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 11 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in S. Ravilly's work include Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (6 papers) and Respiratory viral infections research (5 papers). S. Ravilly is often cited by papers focused on Cystic Fibrosis Research Advances (17 papers), Neonatal Respiratory Health Research (6 papers) and Respiratory viral infections research (5 papers). S. Ravilly collaborates with scholars based in France, United States and Denmark. S. Ravilly's co-authors include D Gendrel, Florence Moulin, Josette Raymond, Charles B. Berde, Mary Ellen B. Wohl, Walter M. Robinson, Evelyne Le Roux, Pierre Palmer, Pierre Lebon and Mathie Lorrot and has published in prestigious journals such as PEDIATRICS, Journal of Clinical Microbiology and Archives of Disease in Childhood.

In The Last Decade

S. Ravilly

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Ravilly France 16 710 345 317 208 169 38 1.2k
Mervyn Shapiro Israel 24 602 0.8× 91 0.3× 397 1.3× 278 1.3× 62 0.4× 53 1.6k
David M. Bamberger United States 19 529 0.7× 295 0.9× 768 2.4× 174 0.8× 87 0.5× 45 1.5k
Marcia R. Moody United States 22 402 0.6× 91 0.3× 291 0.9× 100 0.5× 61 0.4× 43 1.4k
Michelle C. Starr United States 19 252 0.4× 249 0.7× 128 0.4× 152 0.7× 21 0.1× 77 1.1k
John Dotis Greece 19 484 0.7× 101 0.3× 543 1.7× 97 0.5× 71 0.4× 72 1.1k
Moses Grossman United States 19 471 0.7× 309 0.9× 225 0.7× 243 1.2× 15 0.1× 65 1.4k
Gilat Livni Israel 18 475 0.7× 95 0.3× 264 0.8× 134 0.6× 17 0.1× 62 876
A. Colville United Kingdom 11 729 1.0× 176 0.5× 436 1.4× 40 0.2× 69 0.4× 13 1.1k
Efraim Bilavsky Israel 21 792 1.1× 168 0.5× 551 1.7× 200 1.0× 11 0.1× 99 1.4k
Asher Barzilai Israel 20 657 0.9× 145 0.4× 615 1.9× 404 1.9× 16 0.1× 45 1.4k

Countries citing papers authored by S. Ravilly

Since Specialization
Citations

This map shows the geographic impact of S. Ravilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ravilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ravilly more than expected).

Fields of papers citing papers by S. Ravilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ravilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ravilly. The network helps show where S. Ravilly may publish in the future.

Co-authorship network of co-authors of S. Ravilly

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ravilly. A scholar is included among the top collaborators of S. Ravilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ravilly. S. Ravilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lévy, Corinne, Robert Cohen, Stéphane Béchet, et al.. (2023). Pediatric ambulatory pertussis epidemiology in France, recent updates. Infectious Diseases Now. 53(6). 104727–104727. 2 indexed citations
2.
3.
Marchand, Claire, Anne Le Rhun, S. Ravilly, et al.. (2013). Motivations et freins à la greffe chez patients, aidants et médecins dans la mucoviscidose. Revue des Maladies Respiratoires. 31(3). 237–247. 2 indexed citations
4.
Catherinot, Émilie, Anne‐Laure Roux, Marie‐Anne Vibet, et al.. (2012). Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. Journal of Cystic Fibrosis. 12(1). 74–80. 76 indexed citations
5.
Boëlle, Pierre‐Yves, Laura Viviani, Hanne Vebert Olesen, et al.. (2012). Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis. Orphanet Journal of Rare Diseases. 7(1). 64–64. 23 indexed citations
6.
David, Valérie, et al.. (2008). Le conducteur pédagogique : une aide pour mener des séances d’éducation thérapeutique. Revue des Maladies Respiratoires. 25(10). 1322–1325. 7 indexed citations
7.
David, Valérie, et al.. (2008). Éducation thérapeutique et mucoviscidose de l’enfant : compétences, objectifs et conducteurs. Archives de Pédiatrie. 15(5). 750–752. 2 indexed citations
8.
Dubus, J.‐C. & S. Ravilly. (2008). Aérosolthérapie dans la mucoviscidose. Revue des Maladies Respiratoires. 25(8). 989–998. 5 indexed citations
9.
Deschildre, A., et al.. (2007). Educational Practice for Inhaled Treatments in French Cystic Fibrosis Care Centers. Journal of Aerosol Medicine. 20(2). 105–111. 5 indexed citations
10.
Fauroux, Brigitte, Evelyne Le Roux, S. Ravilly, Gil Bellis, & Annick Clément. (2007). Long-Term Noninvasive Ventilation in Patients with Cystic Fibrosis. Respiration. 76(2). 168–174. 30 indexed citations
11.
David, Valérie, et al.. (2007). L’éducation thérapeutique dans la mucoviscidose : quelles compétences pour le patient ?. Revue des Maladies Respiratoires. 24(1). 57–62. 15 indexed citations
12.
Bellis, Gil, et al.. (2006). Cystic fibrosis mortality trends in France. Journal of Cystic Fibrosis. 6(3). 179–186. 49 indexed citations
13.
Moulin, Florence, E. Marc, Mathie Lorrot, et al.. (2003). Ciprofloxacine après échec des β-lactamines dans les salmonelloses de l’enfant. Archives de Pédiatrie. 10(7). 608–614. 13 indexed citations
14.
Moulin, Florence, E. Marc, Mathie Lorrot, et al.. (2002). Hospitalisations pour gastroentérites aiguës communautaires à rotavirus : une enquête de quatre ans. Archives de Pédiatrie. 9(3). 255–261. 27 indexed citations
15.
Lorrot, Mathie, Florence Moulin, J. Coste, et al.. (2000). [Procalcitonin in pediatric emergencies: comparison with C-reactive protein, interleukin-6 and interferon alpha in the differentiation between bacterial and viral infections].. PubMed. 29(3). 128–34. 33 indexed citations
16.
Gendrel, D, Pierre Palmer, E. Marc, et al.. (1999). Coïncidence des épidémies de rotavirus et de virus respiratoire syncytial à Paris : une enquête de 1993 à 1998. Archives de Pédiatrie. 6(7). 735–739. 26 indexed citations
17.
Ravilly, S., et al.. (1999). Thoracoabdominal asynchrony and ratio of time to peak tidal expiratory flow over total expiratory time in adolescents with cystic fibrosis. Pediatric Pulmonology. 28(3). 199–204. 7 indexed citations
18.
Gendrel, D, Josette Raymond, Joël Coste, et al.. (1999). Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. The Pediatric Infectious Disease Journal. 18(10). 875–881. 254 indexed citations
19.
Gendrel, D, Josette Raymond, Florence Moulin, et al.. (1997). Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. European Journal of Clinical Microbiology & Infectious Diseases. 16(5). 388–391. 112 indexed citations
20.
Moulin, Florence, et al.. (1996). Serum alpha-interferon in lower respiratory tract infections of children. The Pediatric Infectious Disease Journal. 15(10). 883–886. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mervyn Shapiro Breakdown of academic impact, for papers by David M. Bamberger Breakdown of academic impact, for papers by Marcia R. Moody Breakdown of academic impact, for papers by Michelle C. Starr Breakdown of academic impact, for papers by John Dotis Breakdown of academic impact, for papers by Moses Grossman Breakdown of academic impact, for papers by Gilat Livni Breakdown of academic impact, for papers by A. Colville Breakdown of academic impact, for papers by Efraim Bilavsky Breakdown of academic impact, for papers by Asher Barzilai
Rankless by CCL
2026